How does Olprinone (OLP) affect NF-κB activation in hepatocytes?

Label:chem

Topic
NF-κB is a critical transcription factor involved in the regulation of inflammatory responses and is often activated in liver injury.
Answer
Olprinone (OLP) inhibited the activation of NF-κB in hepatocytes stimulated with IL-1β. This inhibition was observed through electrophoretic mobility shift assays (EMSA), which showed that OLP suppressed the nuclear translocation and DNA binding ability of NF-κB. This effect likely contributes to the reduction of pro-inflammatory cytokines and chemokines, thereby protecting the liver from endotoxin-induced injury.
Return to Home Chemical List
Knowledge you may be interested in
What histopathological changes are observed in the liver after treatment with Olprinone (OLP)? How does Olprinone (OLP) influence inducible nitric oxide synthase (iNOS) and nitric oxide (NO) production in the liver? What is the effect of Olprinone (OLP) on pro-inflammatory cytokines and chemokines in the liver? How does Olprinone (OLP) affect survival rates in rats subjected to partial hepatectomy and LPS treatment? What is the role of Olprinone (OLP) in hepatoprotection after partial hepatectomy and endotoxin-induced liver injury? What is the role of tacrolimus in preventing acute endothelial graft rejection after penetrating keratoplasty (PKP)? How does tacrolimus perform in treating adenoviral corneal subepithelial infiltrates (SEIs)? What are the advantages of using tacrolimus over corticosteroids in ocular graft-versus-host disease (GVHD)? How effective is tacrolimus in managing dry eye secondary to Sjogren syndrome? What are the common side effects of topical tacrolimus in ocular conditions? What are the potential clinical implications of using Olprinone (OLP) for hepatoprotection? What is the role of lanreotide in the treatment of gastroenteropancreatic neuroendocrine tumors (NETs)? How does lanreotide affect T cell function and survival in vitro? What are the in vivo effects of lanreotide on T cell gene expression in NET patients? Which specific genes were differentially expressed in responders versus non-responders before lanreotide treatment? How does lanreotide treatment affect T cell signaling pathways in vivo? How does the intranasal delivery of granisetron via nanostructured cubosomes improve the management of chemotherapy-induced emesis? What are the key components used to formulate granisetron-loaded cubosomes (GS-CBS)? What is the role of Zileuton in modulating immune responses during coronavirus infection? How does Zileuton affect survival and clinical outcomes in a mouse model of severe acute respiratory syndrome (SARS) caused by mouse hepatitis virus (MHV-3)?